Data Characteristics for This Category
Bispecific antibody clinical trial pre-screening data primarily originates from global clinical trial registries (e.g., ClinicalTrials.gov, EudraCT, ChiCTR) and related academic journals, conference abstracts, and patent databases. Data updates frequently, typically weekly or monthly, due to new trial registrations, status changes, and result publications. Document structures are mainly semi-structured and unstructured, including PDF documents like trial protocols, investigator's brochures, and informed consent forms, alongside structured trial registration forms. Fields and units are highly specialized. For example, dosage units are often mg/kg or mg, time points are weeks, months, days, and biomarker results frequently involve pg/mL, ng/mL, or copy numbers.
Constraints Imposed by These Characteristics on Knowledge Base Retrieval and Recall
Frequent data updates require real-time synchronization capabilities for the knowledge base. It must quickly index new trial information to ensure the timeliness of pre-screening results. Semi-structured and unstructured documents are the primary data sources, demanding robust multimodal parsing capabilities from the knowledge base to accurately extract text, tables, and key entity information from PDFs. Specialized fields and units necessitate optimization for biomedical terminology during text segmentation and entity recognition. This prevents incorrect segmentation or omission of professional terms. For example, critical information like EGFR mutations or PD-1 expression levels must be accurately identified. Furthermore, the complex logical relationships within clinical trial protocols, such as nested inclusion/exclusion criteria, challenge retrieval accuracy and require support for complex query logic.
Configuration Guidelines
| Configuration Item | Recommended Value | Rationale |
|---|---|---|
Chunk size (Segment Length) | 500–800 characters | Clinical trial document paragraphs are of moderate length, balancing semantic completeness and retrieval efficiency. |
Overlap Length | 50–100 characters | Ensures the relevance of key information across segments, preventing context fragmentation. |
Recall count (Recall Count) | 8–12 items | Provides sufficient candidate results, covering potentially relevant information while managing subsequent processing load. |
Similarity threshold (Similarity Threshold) | Calibrate by actual measurement | Adjust based on the semantic similarity distribution for bispecific antibody-related queries to ensure high recall. |
PARSE_FILE_TIMEOUT_SECONDS | 600 seconds | Parsing large PDF documents is time-consuming; this provides ample time to prevent parsing interruptions. |
maxContext | 3000 Tokens | Ensures multiple recalled clinical trial information pieces are fully included in the context, satisfying complex logical judgments. |
Common Pitfalls
- Query results lack critical dosage or administration regimen information. This usually occurs because the knowledge base failed to effectively parse tabular data in PDF documents or separated key numbers and units during text segmentation.
- The user specified particular biomarker requirements, but retrieval results show many irrelevant clinical trials. This indicates insufficient accuracy in the knowledge base's entity recognition module for medical terminology.
- The system returns "Knowledge base retrieval failed" or a related
404error code. This might be because the knowledge base configuration does not correctly link to the specific knowledge base containing bispecific antibody clinical trial data.
Verification Steps
- Upload PDF documents containing bispecific antibody clinical trial protocols. Check if the knowledge base correctly extracts and indexes key fields such as drug names, targets, dosage units, and inclusion/exclusion criteria.
- Execute queries with complex inclusion/exclusion criteria, for example, "PD-1/CTLA-4 bispecific antibody treatment for non-small cell lung cancer, requiring prior platinum-based chemotherapy and no EGFR mutation." Verify if the recalled results accurately match all conditions.
- Periodically update a portion of clinical trial data. Immediately after updating, perform relevant queries to confirm the knowledge base's index update speed and the timeliness of retrieval results.
- Verify the knowledge base switching function via API calls. Ensure that the corresponding bispecific antibody trial knowledge base can be dynamically loaded based on query intent.
The values provided above are common starting points. They should be measured against your own samples to determine the most suitable configuration.
Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.